Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mitsubishi Tanabe Pharma
Biotech
Regeneron scratches 2 drugs from pipeline
Regeneron has axed programs from its pipeline, including a cat allergy drug and an NGF inhibitor for chronic pain.
Gabrielle Masson
Nov 3, 2022 11:05am
Mitsubishi Tanabe, EditForce sign $146M CNS gene therapy deal
Jul 5, 2022 9:20am
Coya Therapeutics eyes IPO, 2022 trial for ALS hopeful
Aug 3, 2021 11:37am
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
Apr 25, 2019 9:10am
Akebia’s Japanese vadadustat data ‘bode well’ for larger trials
Mar 13, 2019 11:16am
Mitsubishi Tanabe, Hitachi join forces in AI-enabled clinical trials
Mar 29, 2018 9:10am
